Eversight

What Eversight does

Eversight is a 501(c)(3) nonprofit eye bank organization headquartered in Ann Arbor, Michigan, with 51-100 employees and offices across Michigan, Illinois, Ohio, New Jersey, Arizona, and South Korea. Founded in 1947 as the Illinois Eye Bank and rebranded to Eversight in 2015 following decades of mergers and acquisitions consolidating regional eye banks, the organization recovers, evaluates, processes, and distributes human donor corneal tissue for sight-restoring transplantation, research, and clinical training. In 2025, Eversight provided 11,260 cornea and eye tissues for transplantation and 3,363 tissues for research, education, and clinical training, drawing on more than 9,800 donors and their families.

The organization's core technology centers on regulatory-compliant tissue processing, including preloaded DMEK (Descemet's membrane endothelial keratoplasty) tissue preparation options such as the EndoGlide product launched in 2023. Eversight Academy delivers surgeon education through on-demand training, webinars, wet lab programs, and the Young Physicians Group, with 76 training sessions delivered to 787 surgeons across 44 countries in 2025. The Eye & Vision Research Grants program funds academic research at institutions including Case Western Reserve, Northwestern, University of Michigan, and Wayne State, while the Eversight Center for Vision and Eye Banking Research in Cleveland pursues therapies for non-corneal vision loss.

Eversight's revenue model is a hybrid of tissue service fees charged to surgeons and hospitals, individual and corporate charitable donations (one-time gifts, recurring Sustainers for Sight contributions, corporate matching, donor-advised funds, planned giving, and gifts of stock), grants, and fees for research tissue and R&D services. The go-to-market is a hybrid of direct sales (surgeon tissue requests, hospital and OPO partnerships, global aid distribution, Eversight Academy training) and community engagement (Lions Clubs partnerships, donor registration, volunteer programs, fundraising events). The organization has earned 33 Top Workplaces and Culture Excellence awards since 2022 and holds the Candid Platinum Seal of Transparency, with governance by a Board of Directors led by President/CEO Diane Hollingsworth.

Name

Eversight

Legal name

Eversight, Inc.

Website

https://eversightvision.org

Company type

Private

Founded year

1947

Operating status

Operating

Headcount range

51–100 employees

Short description

Eversight is a 501(c)(3) nonprofit eye bank that recovers, processes, and distributes donor corneal tissue for transplantation, research, and surgeon education across multiple U.S. states and South Korea, serving surgeons, transplant recipients, donors, and academic researchers.

Ownership category

akta.pro rank

Product category

Eye Banking Services

NAICS

Offices of Optometrists (62132)

SIC

Ophthalmic Goods (3851)

akta.pro primary industry

Comprehensive Eye Exams & Vision Care (HLAKAKAA)

akta.pro secondary industry

Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging) (HLAFAKAI)

Keywords

• Eye banking services
• Corneal transplantation
• Donor tissue recovery
• Vision research grants
• Surgeon education programs

Headquarters

HQ city

Ann Arbor

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Charitable Donations: Individual donors contribute financial support through one-time gifts, recurring monthly contributions (Sustainers for Sight), and planned giving arrangements. Donations support tissue processing, surgeon training, research grants, and global aid programs.
2. Corporate Philanthropy: Corporate matching gift programs and company partnerships maximize employee contributions. Employer matching programs are promoted to double individual donation impact.
3. Donor-Advised Funds: Contributions through donor-advised funds (DAFs) allow donors to grow investments in Eversight's mission with tax advantages. Eversight accepts gifts from all DAF platforms.
4. Planned Giving: Planned gifts through wills, trusts, IRA charitable rollovers, and life insurance beneficiary designations provide substantial long-term impact. Members of the Visionary Society receive recognition for these commitments.
5. Gifts of Stock: Donors can bypass capital gains tax by donating appreciated stocks directly to Eversight, receiving an income tax deduction while supporting the mission.

Pricing tiers

Go-to-market motion3 records

Distribution channels7 records

Marketing channels10 records

Core offering

Eversight is a nonprofit eye bank network that recovers, evaluates, processes, and distributes donor human eye tissue (primarily corneal tissue) for sight-restoring transplantation. Beyond tissue distribution, it funds academic eye and vision research through its Eye & Vision Research Grants Program, trains surgeons via Eversight Academy, and extends services globally through its Global Aid Program and international eye bank partnerships.

Product overview

Eversight operates as a network of nonprofit eye banks providing a comprehensive suite of eye donation, transplantation, and vision research services. The core offerings include eye tissue recovery and transplantation services, the Eye & Vision Research Grants Program funding academic research, and Eversight Academy offering surgeon education through on-demand training, webinars, and the Young Physicians Group. The Global Aid Program extends services internationally, while the Donation Support Center handles 24/7 donor coordination. Preloaded tissue preparation options like DMEK EndoGlide streamline surgical procedures for partner surgeons. The organization also provides the monthly Insight newsletter for stakeholder communication. Together, these products form an integrated ecosystem supporting the full spectrum from eye donation through transplantation and research advancement.

Differentiator

Problem solved

Functional benefit

Products and services

• Eye Tissue for Transplantation
• Eversight Academy
• Global Aid Program
• Preloaded DMEK Tissue Options Preloaded corneal tissue preparation options (including the DMEK EndoGlide) that streamline Descemet's membrane endothelial keratoplasty surgery, reduce surgical cost, and provide added control during transplantation procedures.
• Eye & Vision Research Grants Program Annual grant program funding promising eye and vision research at academic institutions (including Case Western Reserve University, Northwestern University, University of Michigan, and Wayne State University) to advance understanding and treatment of blinding eye conditions.
• Donor Registry Support Support for organ, eye, and tissue donor registration through state motor vehicle departments and the National Donate Life Registry (RegisterMe.org), enabling the donation process that supplies tissue for transplantation.

Quantifiable outcome

• 11,260 cornea and eye tissues provided for transplantation in 2025
• +3 more outcomes

Named customers5 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• Case Western Reserve UniversityminorStrategic or Co-development Partner · 1 January 20262026 Eversight Eye & Vision Research grant recipient investigating enhanced OCT contrast linked to corneal microstructure to improve outcomes for LASIK and other refractive surgeries.
• Northwestern UniversityminorStrategic or Co-development Partner · 1 January 20262026 Eversight Eye & Vision Research grant recipient investigating bioengineered ACE2 as a potential therapeutic for limbal stem cell deficiency.
• University of MichiganminorStrategic or Co-development Partner · 1 January 20262026 Eversight Eye & Vision Research grant recipient investigating rapid and precise refractive and geometric characterization of the anterior segment through computational optical imaging.
• Wayne State UniversityminorStrategic or Co-development Partner · 1 January 20262026 Eversight Eye & Vision Research grant recipient investigating cyclic antimicrobial peptides for safe and effective treatment of bacterial keratitis.
• St. John Eye HospitalcoreStrategic or Co-development Partner · 1 December 2025Partnership with St. John Eye Hospital in East Jerusalem, the only charitable provider of expert eye care in the region. Through Eversight's global aid program, the partnership provided corneal tissue for 11 sight-restoring transplants for patients who had waited years for care. The hospital serves patients from East Jerusalem and the West Bank who face significant barriers to accessing eye care.
• Lions Clubs InternationalcoreStrategic or Co-development Partner · 1 April 2025Lions Clubs are key community partners for Eversight, supporting donation awareness, fundraising, and volunteer activities. The partnership leverages Lions Club networks at the local level to promote the gift of sight and support Eversight's mission in communities across the organization's service areas.
• Gift of Life MichigancoreStrategic or Co-development Partner · 1 April 2023Gift of Life Michigan is the state's federally designated organ and tissue recovery program maintaining the Michigan Organ Donor Registry in partnership with the Department of State. Eversight partners with Gift of Life to make the gift of sight possible through eye donation, corneal transplantation and vision research.
• Michigan Secretary of StatecoreStrategic or Co-development Partner · 1 April 2023Partnership with Michigan Secretary of State Jocelyn Benson to promote National Donate Life Month and encourage Michiganders to register as organ donors. Secretary of State offices process the majority of donor registrations in Michigan.
• Donor Network of ArizonacoreStrategic or Co-development Partner · 1 January 2023Partnership with Donor Network of Arizona, the state's federally designated organ procurement organization, to expand eye banking services in Arizona. The collaboration enables Eversight to serve surgeons and patients in the Arizona region.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Alcon: Largest pure-play ophthalmic medical device and surgical equipment company. Serves the same corneal/ophthalmic surgeon customer base as Eversight but operates upstream in devices, IOLs, and surgical consumables.
• Johnson & Johnson Vision: Global vision-care division of J&J covering cataract surgery, contact lenses, and refractive surgery. Operates broadly in the ophthalmology ecosystem where Eversight's surgeon customers make purchasing decisions.
• Bausch + Lomb: Global ophthalmic products and surgical device company (Bausch + Lomb, a Bausch Health subsidiary). Operates broadly in vision care and corneal surgery — overlapping with Eversight's surgeon customers — but as a portfolio incumbent rather than an eye-bank specialist.

Direct peers

• Iowa Lions Eye Bank: Lions-affiliated nonprofit eye bank with comparable donor-network model and tissue distribution services. Operates under similar Lions Club partnership dynamics that Eversight leverages.
• San Diego Eye Bank: Nonprofit community eye bank providing tissue recovery, processing, and distribution for corneal transplantation. Directly comparable to Eversight on service mix (transplantation + research + education) and nonprofit governance.
• CorneaGen: For-profit US eye bank distributing corneal tissue for transplantation with surgeon support services. Most direct for-profit competitor to Eversight's core transplantation business, operating on a similar tissue-supply-plus-services model.
• Vision Share: Consortium of US eye banks that aggregate tissue supply and distribute to surgeons nationwide. Competes with Eversight in the surgeon-tissue channel and represents a structural alternative to single-bank procurement.
• Advancing Sight Network (formerly SightLife): Nonprofit eye bank providing corneal tissue, surgeon training, and global blindness prevention programs. Closest US nonprofit peer to Eversight, with overlapping mission, donor-network GTM, and global aid footprint.

Others

• MTF Biologics: Nonprofit tissue bank focused on musculoskeletal and other donated tissues for transplantation. Adjacent to Eversight on the nonprofit tissue-banking operating model and FDA compliance infrastructure, but not a direct competitor.

Emerging players

• Versiti: Nonprofit blood and tissue bank with expanding tissue recovery operations. Comparable nonprofit governance and donor-supply model, with emerging adjacency into eye banking that could compete with Eversight's tissue sourcing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/eversightvision
• YouTubeyoutube.com/@eversightvision
• Facebookfacebook.com/eversightvision
• LinkedInlinkedin.com/company/eversight-vision
• Instagraminstagram.com/eversightvision

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eversight